GC Cell is a global biotech company that has established a full-cycle value chain spanning research and development, commercialization, and distribution in the cell and gene therapy (CGT) sector.

In particular, through its CGT-specialized CDMO business, the company boasts Asia's largest manufacturing capacity and a global network linked with North American affiliates (such as BioCentric). We provide a 360-degree one-stop B2B solution, ranging from essential regulatory testing services (such as viral safety testing and mycoplasma testing) to process and analytical development (CDO), clinical and commercial GMP manufacturing (CMO), and cold-chain logistics. Furthermore, we offer comprehensive support services for advanced regenerative medicine clinical research, including joint project collaboration, contract manufacturing, and RA (Regulatory Affairs) consulting. Backed by years of commercialization experience, GC Cell reliably empowers our partners to successfully enter global markets.